BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 21228554)

  • 1. Nail psoriasis successfully treated with intralesional methotrexate: case report.
    Sarıcaoglu H; Oz A; Turan H
    Dermatology; 2011 Feb; 222(1):5-7. PubMed ID: 21228554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe 20-nail psoriasis successfully treated by low dose methotrexate.
    Lee JY
    Dermatol Online J; 2009 Nov; 15(11):8. PubMed ID: 19951644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Nail Psoriasis Successfully Treated with Intralesional Methotrexate.
    Mokni S; Ameur K; Ghariani N; Sriha B; Belajouza C; Denguezli M; Nouira R
    Dermatol Ther (Heidelb); 2018 Dec; 8(4):647-651. PubMed ID: 30255281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nail psoriasis improvement in a patient treated with fumaric acid esters.
    Vlachou C; Berth-Jones J
    J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab in psoriasis and psoriatic arthritis.
    Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of a 12-week course of alefacept on nail psoriasis.
    Körver JE; Langewouters AM; Van De Kerkhof PC; Pasch MC
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1252-5. PubMed ID: 17062041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: A comparative study.
    Abdelmeniem IM; El Eryan IM; Nofal A; Fouda I; Omar SS
    Dermatol Ther; 2022 Sep; 35(9):e15660. PubMed ID: 35730342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
    Eskicirak B; Zemheri E; Cerkezoglu A
    Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramatricial injections for nail psoriasis: An open-label comparative study of triamcinolone, methotrexate, and cyclosporine.
    Mittal J; Mahajan BB
    Indian J Dermatol Venereol Leprol; 2018; 84(4):419-423. PubMed ID: 29536977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin-6 levels in response to methotrexate treatment in psoriatic patients.
    Elango T; Dayalan H; Subramanian S; Gnanaraj P; Malligarjunan H
    Clin Chim Acta; 2012 Oct; 413(19-20):1652-6. PubMed ID: 22609260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
    Kaur I; Dogra S; De D; Kanwar AJ
    Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory nail conditions. Part 1: nail changes in psoriasis.
    Yesudian PD; de Berker DAR
    Clin Exp Dermatol; 2021 Jan; 46(1):9-15. PubMed ID: 33220008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
    Jiaravuthisan MM; Sasseville D; Vender RB; Murphy F; Muhn CY
    J Am Acad Dermatol; 2007 Jul; 57(1):1-27. PubMed ID: 17572277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of psoriatic nail lesions therapy by means of nail psoriasis severity index].
    Tsiskarishvili NV; Katsitadze AG; Tsiskarishvili NI
    Georgian Med News; 2011 Oct; (199):43-7. PubMed ID: 22155805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
    Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
    Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
    Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to managing patients with nail psoriasis.
    Reich K
    J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():15-21. PubMed ID: 19686381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.